Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANVS compared with ECX: revenue, margins and what each company keeps, and the suppliers and customers both name
ANVS
Annovis Bio, Inc.
Change
Mkt cap
Revenue
Revenue
ECX
ECARX Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANVS
Annovis Bio, Inc.
vs
ECX
ECARX Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ANVS: latest quarter not drawable. ECX: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANVS, solid
ECX, dashed
ANVS
Annovis Bio, Inc.
Change
1.14
▲
+11.86%
· post 1.13
Mkt cap
$48.1M
ECX
ECARX Holdings Inc.
Change
0.89
▲
+11.20%
· post 0.89
Closed
Oct 30 '26
Mkt cap
$319.0M
vs
Compare
Closed
Oct 30 '26
ANVS
Annovis Bio, Inc.
vs
ECX
ECARX Holdings Inc.
1.14
▲
+11.86%
post 1.13
Price
0.89
▲
+11.20%
post 0.89
$48.1M
Mkt cap
$319.0M
Change
Change
ANVS
1.14
▲
+11.86%
vs
ECX
0.89
▲
+11.20%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ANVS
1
—
Alzheimer's Disease Cooperative Study ("ADCS")
unlisted
supplier
Shared
0
No disclosed counterparties: ECX.
Only ECX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR